Gastrointestinal Cancer: Drugs
(asked on 23rd January 2015) - View Source
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government why the Cancer Drugs Fund has classified gastrointestinal stromal tumours as a normal cancer rather than a rare cancer in relation to its appraisal of regorafenib.
This question was answered on 3rd February 2015
The Cancer Drugs Fund has not classed gastrointestinal stromal tumours as a normal cancer and recognises it as a rare cancer. However, it does not recognise regorafenib as a drug that treats rare cancers alone as it has a European licence for bowel cancer.